Avanos Medical (AVNS) Stock Statistics & Valuation Metrics

Avanos Medical has a market cap or net worth of $624.54M. The enterprise value is $663.84M.

Avanos Medical has 46,503,456 shares outstanding. The number of shares has decreased by -2.65% in one year.

Avanos Medical’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -6.65%.

The current PE Ratio of Avanos Medical is 35.2. Avanos Medical’s PEG ratio is 0.09.

In the last 12 months, Avanos Medical had revenue of 701.20M and earned -67.90M in profits. Earnings per share was -1.46.

In the last 12 months, operating cash flow was 74.70M and capital expenditures -31.60M, giving a free cash flow of 43.10M billion.

Avanos Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Avanos Medical upcoming earnings date is May 6, 2026, Before Open (Confirmed).

Avanos Medical as a current ratio of 2.15, with Debt / Equity ratio of 16.59%

In the past 12 months, Avanos Medical has paid 1.70M in taxes.

Avanos Medical EV to EBITDA ratio is -16.88, with an EV/FCF ratio of 13.00.

Avanos Medical has $89.80M in cash and marketable securities with $129.10M in debt, giving a net cash position of -$39.30M billion.

Gross margin is 49.77%, with operating margin of -8.78%, and net profit margin of -9.68%.

The average price target for Avanos Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―